% | $
Quotes you view appear here for quick access.


you are viewing a single comment's thread.

view the rest of the posts
  • mosesnoses mosesnoses Feb 15, 2000 8:13 PM Flag


    The big difference between NASI and SCOR is that
    SCOR is late to the market with seeds while NASI is
    already moving beyond seeds with its aquisition of
    Theseus and its restenosis treatment with partner ESON.
    Apomate has an enormous potential market, far ex-seeding
    any prostate treatment!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The late arrival of Syncor seeds just stresses
      the unerlying difference between North American and
      Syncor. NASI is a focused growing company while Syncor
      relies on their market share to make money on also-ran
      products. NASI will probably continue to use capital to
      market new products while Syncor will use revenue to
      give their employees a reason to sell goods.

    • is that SCOR is a 500M company with over 50% of
      its market share (in its core radiological
      pharmaceuticals) while NASI is a 20M company hoping to displace
      others as its core (radioactive callibration sources)
      continues to erode. Both are under valued.

    • If you ascribe to IBD's theories, up on big volume after a base pattern bodes well for us. Your also right on with the long term chart pattern, looks good into low 20's.